Clinical trial Recruiting at 1 site Interventional Ages 20 to 75 Women only

Endoscopic mastectomy for breast cancer patients

Official title: Feasibility and Acceptability of Endoscopic Mastectomy in Patients With Breast Cancer

Run by University Hospital, Montpellier · NCT06569706 · Data updated 2026-11-12

This study is testing a new way to perform nipple-sparing mastectomy with immediate breast reconstruction for women with small to medium breasts and breast cancer to see if it is safe and effective while leaving less scarring.

Quick facts

Study typeInterventional
Ages20 Years to 75 Years
SexWomen only
Enrollment20 (estimated)
SponsorUniversity Hospital, Montpellier
Academic / other
Drugs / interventionsradiation
Locations1 site (Montpellier)
StatusRecruiting
StartedOctober 18, 2024
Main results expectedOctober 18, 2026
Study endsOctober 18, 2029
Registry record updatedJanuary 5, 2026
Trial IDNCT06569706 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 20 to 75 with breast cancer indications for mastectomy and cup sizes A, B, or C.

Probably not a fit

Patients with inflammatory breast cancer, cutaneous carcinoma, or those who have had prior oncological surgery on the same breast may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility and safety of endoscopic nipple-sparing mastectomy with immediate breast reconstruction for breast cancer patients. It focuses on women with small to medium breast sizes who require mastectomy due to specific cancer indications. The approach utilizes a single-port device to minimize scarring and reduce costs compared to robotic techniques. The study will assess various outcomes including operative time, infection rates, aesthetic results, and oncological safety.

Why it matters

Potential benefit: If successful, this technique could provide a less invasive surgical option with improved cosmetic outcomes for breast cancer patients.

How similar studies have gone: Feasibility and safety studies of similar endoscopic approaches have been limited to Asia, making this research novel for Europe.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women between 20 and 75 years.
* Patient with an indication for curative mastectomy, either unilateral or bilateral, with nipple preservation:

  * Extensive Carcinoma In Situ (CIS), more than 2 cm from the nipple
  * Multicentric Infiltrating Carcinoma (IC), more than 2 cm from the nipple
  * Large volume Infiltrating Carcinoma, more than 2 cm from the nipple
  * IC or CIS for which the patient refuses conservative treatment, more than 2 cm from the nipple
* Breast volumes: cup sizes A, B, or C as defined by underwear size, and glandular ptosis not exceeding grade 2 according to Regnault's classification
* Patient wishing to undergo immediate breast reconstruction.
* WHO/OMS (World Health Organization/Organisation Mondiale de la Santé) performance status \<3

Exclusion Criteria:

* Cutaneous carcinoma
* Inflammatory breast
* History of oncological breast surgery on the same breast
* Patient who has received radiation treatment on the same breast
* Breast hypertrophy requiring a nipple-bearing flap
* Smoking ≥ 10 cigarettes/day
* BMI \> 35
* Protected patient or unable to give consent according to Article L1121-8 of the French Public Health Code (CSP).
* Patient participating in another interventional clinical study.
* ASA (physical status score of the American Society of Anesthesiologists) \>2.
* Pregnant or breastfeeding women according to Article L1121-5 of the CSP.
* Vulnerable persons (those receiving psychiatric care, those deprived of liberty, and those admitted to a health or social institution) according to Article L1121-6 of the CSP.
* Absence of effective contraception for patients of childbearing age.
* Absence of affiliation with a social security scheme.
* Absence of collected free, informed, and written consent.

Where it's running

  • Uhmontpellier
    Montpellier, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.